Saudi Arabia started its path to improve traceability and visibility in the pharma supply chain in 2015, making medicines safer and preventing counterfeiting through serialization. Unlike in Europe, a complete track-and-trace system, including aggregation processes, is introduced.
Introducing a track-and-trace system in Saudi Arabia is part of the Saudi government’s Vision 2030 program. By 2030, Saudi Arabia wants to track all medicines and healthcare products registered for human use, domestically and internationally.
Designation: Drug Track and Trace System for Pharmaceutical Products (RSD)
Competent authority: Saudi Food and Drug Authority (SFDA)
Products: All medicines for humans and animals
Code type: GS1 Data Matrix
Aggregation: Yes, according to GS1 standards
Timeframe: Start December 2015, serialization from 2017, a complete implementation in 2022.
Since October 2019, the aggregation of single packages has been mandatory in Saudi Arabia. From now on, an 18-digit Serial Shipping Container Code (SSCC) is obligatory printed at the pallet level. Firstly, only human medicines will be tracked throughout the supply chain. The measures will be expanded to include herbal and other healthcare products and medicines for animals.
SoftGroup provides an end-to-end solution for complying with all requirements of the Saudi Arabia National Track & Trace System – RSD digital platform.
The solution ensures a connection and data exchange between the National Track & Trace System – RSD digital platform and all shareholders (MAHs, Manufacturers, Importers, Distributors, etc.).
Despite your role within the supply chain (MAHs, Manufacturer, Importer or distributor), you can easily upload the required product master data (PMD) of imported or produced medicines, herbs, and health drugs and publish the product pack data (PPD), including serial and aggregation reports of all packaging levels.